KalVista Pharmaceuticals, Inc. reports

Company location: Framingham, MA
Fiscal year end: 31 December

KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 326-350 of 882 matching filings.

Per page

25

Current page

14

S-8 File 333-272777

S-8

Filing date: 20 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36830

8-K

Filing date: 14 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 22 May 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 22 May 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 22 May 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 22 May 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 22 May 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 May 2023
Reporting date: 18 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2023
Reporting date: 11 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2023
Reporting date: 11 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2023
Reporting date: 11 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2023
Reporting date: 11 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2023
Reporting date: 11 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-88797

SC 13G filing

Filing date: 10 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36830

8-K

Filing date: 09 Mar 2023
Reporting date: 09 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36830

10-Q

Filing date: 09 Mar 2023
Reporting date: 31 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 17 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88797

SC 13G/A filing

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88797

AMENDMENT NO. 1

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88797

SC 13G/A filing

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88797

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .